NSE BSE
ipca laboratories ltd stock

IPCA LABORATORIES LTD Share Price

- - (%)
- NSE: IPCALAB

IPCA LABORATORIES LTD Share Price Update

As of the latest trading session, IPCA LABORATORIES LTD share price is currently at 1218.2, which is down by -9.35 from its previous closing. Today, the stock has fluctuated between 1206.05 and 1237.00. Over the past year, IPCA LABORATORIES LTD has achieved a return of 56.03 %. In the last month alone, the return has been 5.56 %. Read More...

IPCA LABORATORIES LTD Performance

Day Range

Low1206.05 High1237.00
1218.20

52 Week Range

Low 775.05 High 1374.60
1218.20

IPCA LABORATORIES LTD Share Price

1633

524494

IPCALAB

img img img img
No Data Available

Open Price

1234.75

Prev. Close

1227.55

Volume (Shares)

375305.00

Total traded value

4571.96

Upper Circuit

1350.30

Lower Circuit

1104.80

Note: The current prices & values are delayed, Login to your account for live updates.

IPCA LABORATORIES LTD Fundamentals


(Standalone)

Market Cap (Cr) 30906.25
PE Ratio (TTM) 58.70
Book Value / Share 250.24
Beta 0.38
ROE 8.91%
EPS (TTM) 24.30
Dividend Yield 0.16%
Net Profit Qtr (Cr) 64.76

IPCA LABORATORIES LTD Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars MAR 2024 (Values in Cr)
Revenue 1510.62
Operating Expense 1304.10
Net Profit 64.76
Net Profit Margin (%) 4.28
Earnings Per Share (EPS) 2.55
EBITDA 213.11
Effective Tax Rate (%) 49.12
Particulars DEC 2023 (Values in Cr)
Revenue 1506.83
Operating Expense 1324.02
Net Profit 136.94
Net Profit Margin (%) 9.08
Earnings Per Share (EPS) 5.40
EBITDA 290.38
Effective Tax Rate (%) 31.58
Particulars SEP 2023 (Values in Cr)
Revenue 1662.67
Operating Expense 1453.68
Net Profit 162.13
Net Profit Margin (%) 9.75
Earnings Per Share (EPS) 6.39
EBITDA 345.12
Effective Tax Rate (%) 33.85
Particulars JUN 2023 (Values in Cr)
Revenue 1486.34
Operating Expense 1279.92
Net Profit 166.58
Net Profit Margin (%) 11.20
Earnings Per Share (EPS) 6.57
EBITDA 340.69
Effective Tax Rate (%) 33.25
Particulars MAR 2023 (Values in Cr)
Revenue 1401.63
Operating Expense 1302.89
Net Profit 84.82
Net Profit Margin (%) 6.05
Earnings Per Share (EPS) 3.34
EBITDA 209.11
Effective Tax Rate (%) 35.84
Particulars MAR 2024 (Values in Cr)
Revenue 6166.46
Operating Expense 5322.23
Net Profit 530.41
Net Profit Margin (%) 8.60
Earnings Per Share (EPS) 20.91
EBITDA 1189.31
Effective Tax Rate (%) 35.48
Particulars MAR 2023 (Values in Cr)
Revenue 5814.62
Operating Expense 5175.32
Net Profit 505.70
Net Profit Margin (%) 8.69
Earnings Per Share (EPS) 19.93
EBITDA 1023.04
Effective Tax Rate (%) 32.61
Particulars MAR 2022 (Values in Cr)
Revenue 5438.30
Operating Expense 4417.11
Net Profit 860.37
Net Profit Margin (%) 15.82
Earnings Per Share (EPS) 33.91
EBITDA 1291.00
Effective Tax Rate (%) 19.89
Particulars MAR 2021 (Values in Cr)
Revenue 5139.16
Operating Expense 3821.44
Net Profit 1140.77
Net Profit Margin (%) 22.19
Earnings Per Share (EPS) 90.08
EBITDA 1575.82
Effective Tax Rate (%) 17.33
Particulars MAR 2020 (Values in Cr)
Revenue 4367.43
Operating Expense 3647.15
Net Profit 652.46
Net Profit Margin (%) 14.93
Earnings Per Share (EPS) 51.64
EBITDA 979.45
Effective Tax Rate (%) 16.88
Particulars MAR 2023 (Values in Cr)
Book Value / Share 230.27
ROE % 8.70
ROCE % 11.59
Total Debt to Total Equity 0.20
EBITDA Margin 16.90
Particulars MAR 2022 (Values in Cr)
Book Value / Share 215.41
ROE % 17.92
ROCE % 20.26
Total Debt to Total Equity 0.11
EBITDA Margin 23.66
Particulars MAR 2021 (Values in Cr)
Book Value / Share 370.65
ROE % 27.59
ROCE % 30.56
Total Debt to Total Equity 0.09
EBITDA Margin 29.71
Particulars MAR 2020 (Values in Cr)
Book Value / Share 286.15
ROE % 17.88
ROCE % 19.51
Total Debt to Total Equity 0.14
EBITDA Margin 20.85
Particulars MAR 2019 (Values in Cr)
Book Value / Share 247.12
ROE % 15.22
ROCE % 16.35
Total Debt to Total Equity 0.19
EBITDA Margin 19.91
Particulars MAR 2023 (Values in Cr)
Book Value / Share 231.66
ROE % 8.91
ROCE % 11.67
Total Debt to Total Equity 0.20
EBITDA Margin 17.64
Particulars MAR 2022 (Values in Cr)
Book Value / Share 215.84
ROE % 16.82
ROCE % 19.15
Total Debt to Total Equity 0.10
EBITDA Margin 23.80
Particulars MAR 2021 (Values in Cr)
Book Value / Share 374.67
ROE % 27.06
ROCE % 30.20
Total Debt to Total Equity 0.08
EBITDA Margin 30.72
Particulars MAR 2020 (Values in Cr)
Book Value / Share 290.11
ROE % 19.15
ROCE % 20.63
Total Debt to Total Equity 0.13
EBITDA Margin 22.50
Particulars MAR 2019 (Values in Cr)
Book Value / Share 248.25
ROE % 15.60
ROCE % 16.63
Total Debt to Total Equity 0.18
EBITDA Margin 20.65
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 1853.24
Total Assets 8626.43
Total Liabilities 8626.43
Total Equity 5915.32
Share Outstanding 253704218
Price to Book Ratio 3.50
Return on Assets (%) 5.46
Return on Capital (%) 6.39
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 640.66
Total Assets 7623.53
Total Liabilities 7623.53
Total Equity 5541.76
Share Outstanding 253704218
Price to Book Ratio 4.92
Return on Assets (%) 11.59
Return on Capital (%) 13.96
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 365.07
Total Assets 6068.36
Total Liabilities 6068.36
Total Equity 4716.18
Share Outstanding 126852109
Price to Book Ratio 5.08
Return on Assets (%) 18.78
Return on Capital (%) 22.94
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 180.92
Total Assets 5259.83
Total Liabilities 5259.83
Total Equity 3641.11
Share Outstanding 126352109
Price to Book Ratio 4.78
Return on Assets (%) 11.52
Return on Capital (%) 14.95
Particulars MAR 2019 (Values in Cr)
Cash & Short Term Investments 282.30
Total Assets 4550.67
Total Liabilities 4550.67
Total Equity 3137.93
Share Outstanding 126352109
Price to Book Ratio 3.96
Return on Assets (%) 9.77
Return on Capital (%) 12.75
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 1706.06
Total Assets 8446.97
Total Liabilities 8446.97
Total Equity 5877.30
Share Outstanding 253704218
Price to Book Ratio 3.50
Return on Assets (%) 5.98
Return on Capital (%) 6.93
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 595.50
Total Assets 7438.44
Total Liabilities 7438.44
Total Equity 5475.76
Share Outstanding 253704218
Price to Book Ratio 4.92
Return on Assets (%) 11.56
Return on Capital (%) 13.8
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 306.92
Total Assets 6010.13
Total Liabilities 6010.13
Total Equity 4752.72
Share Outstanding 126852109
Price to Book Ratio 5.08
Return on Assets (%) 18.98
Return on Capital (%) 22.93
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 152.40
Total Assets 5184.57
Total Liabilities 5184.57
Total Equity 3677.54
Share Outstanding 126352109
Price to Book Ratio 4.78
Return on Assets (%) 12.58
Return on Capital (%) 16.05
Particulars MAR 2019 (Values in Cr)
Cash & Short Term Investments 259.81
Total Assets 4457.54
Total Liabilities 4457.54
Total Equity 3136.66
Share Outstanding 126352109
Price to Book Ratio 3.96
Return on Assets (%) 10.20
Return on Capital (%) 13.12
Particulars MAR 2023 (Values in Cr)
Net Income 745.29
Cash from Operations 1029.46
Cash from Investing -725.00
Cash from Financing 507.24
Net change in Cash 588.05
Free Cash Flow 1523.93
Particulars MAR 2022 (Values in Cr)
Net Income 1135.72
Cash from Operations 1058.11
Cash from Investing -855.05
Cash from Financing 426.78
Net change in Cash 427.80
Free Cash Flow 1537.06
Particulars MAR 2021 (Values in Cr)
Net Income 1388.98
Cash from Operations 1335.72
Cash from Investing -520.69
Cash from Financing -305.82
Net change in Cash 263.62
Free Cash Flow 1697.27
Particulars MAR 2020 (Values in Cr)
Net Income 738.89
Cash from Operations 722.57
Cash from Investing -509.65
Cash from Financing -136.54
Net change in Cash -75.84
Free Cash Flow 1028.85
Particulars MAR 2019 (Values in Cr)
Net Income 546.46
Cash from Operations 611.85
Cash from Investing -165.06
Cash from Financing -183.20
Net change in Cash 152.77
Free Cash Flow 792.39
Particulars MAR 2023 (Values in Cr)
Net Income 750.49
Cash from Operations 977.54
Cash from Investing -709.61
Cash from Financing 506.38
Net change in Cash 559.06
Free Cash Flow 1414.40
Particulars MAR 2022 (Values in Cr)
Net Income 1074.11
Cash from Operations 1023.88
Cash from Investing -814.00
Cash from Financing 426.04
Net change in Cash 443.76
Free Cash Flow 1475.51
Particulars MAR 2021 (Values in Cr)
Net Income 1379.96
Cash from Operations 1337.93
Cash from Investing -559.56
Cash from Financing -307.38
Net change in Cash 229.12
Free Cash Flow 1687.58
Particulars MAR 2020 (Values in Cr)
Net Income 784.97
Cash from Operations 707.84
Cash from Investing -499.13
Cash from Financing -138.67
Net change in Cash -76.37
Free Cash Flow 980.91
Particulars MAR 2019 (Values in Cr)
Net Income 557.39
Cash from Operations 603.31
Cash from Investing -122.98
Cash from Financing -222.83
Net change in Cash 149.84
Free Cash Flow 670.71
Company Name Price P/E P/B Market Cap 52 Week Low/High
IPCA LABORATORIES LTD 1227.40 50.64 4.91 31139.66 765.05 / 1373.95
BLISS GVS PHARMA LTD 116.00 12.68 1.25 1214.96 77.65 / 148.95
CIPLA LTD 1516.05 28.75 4.58 122423.77 1020.00 / 1581.70
FERMENTA BIOTECH LIMITED 200.05 0.00 2.03 588.77 136.60 / 219.05
GLAXOSMITHKLINE PHARMA LT 2552.80 65.86 24.32 43245.97 1376.50 / 2759.00
Company Name Price P/E P/B Market Cap 52 Week Low/High
IPCA LABORATORIES LTD 1227.40 50.51 4.90 31139.66 765.05 / 1373.95
AMRUTAJAN HEALTH LTD 744.70 47.86 7.46 2152.97 556.05 / 826.00
ASTRAZENECA PHARMA IND LT 6625.00 110.79 23.26 16562.50 3715.05 / 7550.00
BLISS GVS PHARMA LTD 116.00 15.96 1.22 1214.96 77.65 / 148.95
ABBOTT INDIA LIMITED 28590.80 50.58 16.42 60755.45 21907.45 / 29628.15

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 1220.20
  • 26 Days 1175.60
  • 10 Days 1201.10
  • 50 Days 1212.00
  • 12 Days 1188.90
  • 100 Days 1221.60
  • 20 Days 1182.30
  • 200 Days 941.20
1230.32
PIVOT
First Resistance 1237.08
Second Resistance 1246.62
Third Resistance 1253.38
First Support 1220.78
Second Support 1214.02
Third Support 1204.48
RSI 83.82
MACD 13.23
Commodity Channel Index (CCI) 123.96
ADX 26.11
Williams % R -6.55

Over 1 Month

down

5.56

Over 3 Months

down

-7.53

Over 6 Months

down

7.72

Over 1 Year

down

56.03

Over 3 Years

down

5.42

Over 5 Years

down

20.73

IPCA LABORATORIES LTD Future

Future: Price

30 May
1285.20
27 Jun
1279.60
25 May
0 100 200 300 400 500 600

Discount/Premium

25 Jul
2.90
29 Aug
6.20
25 May
0 1 2 3 4 5 6 7

Active Calls

1400.0
90
1300.0
69
1360.0
60
25 May
0 500 1000 1500 2000 2500 3000

Active Puts

1260.0
96
1200.0
72
1240.0
61
25 Jul
0 500 1000 1500 2000 2500

IPCA LABORATORIES LTD Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Others
14.35
Promoter Holdings
46.3
FII
10.5
DII
28.83
Promoter Shares(Pledge Percentage)
0.0
Name Category Shares Shares%
Kaygee Investments Private Limited Shareholding of Promoter and Promoter Group 5.447839E7 21.47
Dsp Midcap Fund Public Shareholding 1.8080777E7 7.13
Hdfc Mutual Fund - Hdfc Mid-cap Opportunities Fund Public Shareholding 1.7845048E7 7.03
Kaygee Laboratories Private Limited Shareholding of Promoter and Promoter Group 1.677E7 6.61
Chandurkar Investments Private Limited Shareholding of Promoter and Promoter Group 1.395601E7 5.5
Paschim Chemicals Pvt Ltd Shareholding of Promoter and Promoter Group 1.0173E7 4.01
Kotak Emerging Equity Scheme Public Shareholding 9382300.0 3.7
Usha M Chandurkar Shareholding of Promoter and Promoter Group 8302000.0 3.27
Icici Prudential Multi-asset Fund Public Shareholding 6093946.0 2.4
Premchand Godha Shareholding of Promoter and Promoter Group 5814680.0 2.29
Hdfc Life Insurance Company Limited Public Shareholding 4946381.0 1.95
Sbi Life Insurance Co. Ltd Public Shareholding 4647448.0 1.83
Nippon Life India Trustee Ltd-a/c Nippon India Growth Fund Public Shareholding 4301695.0 1.7
Parag Parikh Flexi Cap Fund Public Shareholding 3716750.0 1.46
Kotak Funds - India Midcap Fund Public Shareholding 3450394.0 1.36
Abu Dhabi Investment Authority - Monsoon Public Shareholding 2829935.0 1.12
Uti Flexi Cap Fund Public Shareholding 2643858.0 1.04
Usha Premchand Godha Shareholding of Promoter and Promoter Group 2418740.0 0.95
Sameer M Chandurkar Shareholding of Promoter and Promoter Group 2000000.0 0.79
Pranay Godha Shareholding of Promoter and Promoter Group 1700990.0 0.67
Prashant Godha Shareholding of Promoter and Promoter Group 1568644.0 0.62
Kalpana Jain Shareholding of Promoter and Promoter Group 230000.0 0.09
Mexin Medicaments Private Limited Shareholding of Promoter and Promoter Group 14058.0 0.01
Xbees Traders Llp Shareholding of Promoter and Promoter Group 31000.0 0.01
Makers Laboratories Limited Shareholding of Promoter and Promoter Group 960.0 0.0
Nirmal Jain Shareholding of Promoter and Promoter Group 0.0 0.0
Neetu Godha Shareholding of Promoter and Promoter Group 4000.0 0.0
Bhawna Godha Shareholding of Promoter and Promoter Group 5000.0 0.0

IPCA LABORATORIES LTD

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
2023-11-22 2.0 Interim 2023-11-22 Equity shares 2022-11-22 4.0 Interim 2022-11-23 Equity shares 2021-11-22 8.0 Interim 2021-11-23 Equity shares 2020-11-13 8.0 Interim 2020-11-17 Equity shares 2020-02-18 5.0 Interim 2020-02-20 Equity shares 2019-08-06 3.0 Final 2019-08-08 Equity shares 2018-08-02 1.0 Final 2018-08-04 Equity shares 2017-07-27 1.0 Final 2017-07-29 Equity shares 2015-07-22 1.0 Final 2015-07-24 Equity shares 2014-07-18 2.5 Final 2014-07-22 Equity shares 2013-10-31 2.5 Interim 2013-11-01 Equity shares 2013-07-19 2.0 Final 2013-07-23 Equity shares 2012-11-01 2.0 Interim 2012-11-02 Equity shares 2012-07-20 1.2 Final 2012-07-24 Equity shares 2012-02-07 1.0 Interim 2 2012-02-08 Equity shares 2011-11-03 1.0 Interim 2011-11-07 Equity shares 2011-07-18 1.2 Final 2011-07-20 Equity shares 2011-02-01 1.0 Interim 2 2011-02-02 Equity shares 2010-10-28 1.0 Interim 2010-10-29 Equity shares 2010-07-16 1.0 Final 2010-07-20 Equity shares 2010-01-27 4.0 Interim 2 2010-01-28 Equity shares 2009-10-30 5.0 Interim 2009-11-03 Equity shares 2009-07-20 4.0 Final 2009-07-22 Equity shares 2009-01-27 3.0 Interim 2 2009-01-28 Equity shares 2008-11-07 4.0 Interim 2008-11-10 Equity shares 2008-07-14 4.5 Final 2008-07-16 Equity shares 2007-11-06 3.5 Interim 2007-11-07 Equity shares 2007-07-10 4.0 Final 2007-07-12 Equity shares 2006-11-02 3.5 Interim 0001-01-01 Equity shares 2005-11-09 0.0 Interim 2005-11-10 Equity shares 2005-09-13 0.0 Final 2005-09-15 Equity shares
Ex-Date Ex-Bonus Ratio
2005-01-31 2005-01-28 1:1
Ex-Date Old FV NEW FV Record Date
2022-01-10 2.0 1.0 2022-01-11 2010-03-22 10.0 2.0 2010-03-23

Learn More About Stocks

About IPCA LABORATORIES LTD

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by IPCA LABORATORIES LTD

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 5x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Ipca Laboratories Ltd?

Answer Field

The share price of Ipca Laboratories Ltd for NSE is ₹ 1218.2 and for BSE is ₹ 1221.1.

What is the Market Cap of Ipca Laboratories Ltd?

Answer Field

The market cap of Ipca Laboratories Ltd for NSE is ₹ 30,906.25 Cr. and for BSE is ₹ 30,979.82 Cr. as of now.

What is the 52 Week High and Low of Ipca Laboratories Ltd?

Answer Field

The 52 Week High and Low of Ipca Laboratories Ltd for NSE is ₹ 1374.60 and ₹ 775.05 and for BSE is ₹ 1373.95 and ₹ 765.05.

How to Buy Ipca Laboratories Ltd share?

Answer Field

You can trade in Ipca Laboratories Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Ipca Laboratories Ltd?

Answer Field

The 1 year returns on the stock has been 56.03%.

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

7.5 Lacs+ Users

icon-with-text

4.3+ App Rating

icon-with-text

4 Languages

icon-with-text

₹4300 Cr MTF Book

icon-with-text
loader